CELGENE CORP Contracts & Agreements

Assignment, Assumption and Amendment Agreement, dated as of November 20, 2019, among Bristol-Myers Squibb Company, Celgene Corporation, American Stock Transfer & Trust Company,... (Filed With SEC on November 20, 2019)

Asset Purchase Agreement dated August 25, 2019, by and between Celgene Corporation, as seller, and Amgen Inc., as purchaser (Filed With SEC on August 26, 2019)

First Supplemental Indenture, dated May 1, 2019, to Indenture, dated October 7, 2010 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)

First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 9, 2012 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)

First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 6, 2013 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)

First Supplemental Indenture, dated May 1, 2019, to Indenture, dated May 15, 2014 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)

First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 12, 2015 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)

First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 10, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)

First Supplemental Indenture, dated May 1, 2019, to Indenture, dated November 9, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)

First Supplemental Indenture, dated May 1, 2019, to Indenture, dated February 20, 2018 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust... (Filed With SEC on July 30, 2019)

Form of Contingent Value Rights Agreement by and between Bristol-Myers Squibb Company and [Trustee] (Filed With SEC on January 4, 2019)

Celgene Corporation Executive Severance Plan (Filed With SEC on January 4, 2019)

Agreement and Plan of Merger by and among Bristol-Myers Squibb Company, Burgundy Merger Sub, Inc. and Celgene Corporation, dated as of January 2, 2019 (Filed With SEC on January 4, 2019)

Offer Letter (Filed With SEC on November 2, 2018)

Offer Letter (Filed With SEC on June 1, 2018)

Amended and Restated Credit Agreement, dated as of April 25, 2018 (Filed With SEC on April 30, 2018)

Indenture, dated as of February 20, 2018, relating to the 2.875% Senior Notes due 2021, the 3.250% Senior Notes due 2023, the 3.900% Senior Notes due 2028 and the 4.550% Senior... (Filed With SEC on February 20, 2018)

Form of 2.875% Senior Note due 2021 (Filed With SEC on February 20, 2018)

Form of 3.250% Senior Note due 2023 (Filed With SEC on February 20, 2018)

Form of 3.900% Senior Note due 2028 (Filed With SEC on February 20, 2018)

Form of 4.550% Senior Note due 2048 (Filed With SEC on February 20, 2018)

Underwriting Agreement, dated as of February 8, 2018, among the Company and Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Merrill... (Filed With SEC on February 9, 2018)

Agreement and Plan of Merger, dated as of January 21, 2018, among Celgene Corporation, Blue Magpie Corporation and Juno Therapeutics, Inc (Filed With SEC on January 22, 2018)

Indenture, dated as of November 9, 2017, relating to the 2.750% Senior Notes due 2023, the 3.450% Senior Notes due 2027 and the 4.350% Senior Notes due 2047 between the Company... (Filed With SEC on November 9, 2017)

Form of 2.750% Senior Note due 2023 (Filed With SEC on November 9, 2017)

Form of 3.450% Senior Note due 2027 (Filed With SEC on November 9, 2017)

Form of 4.350% Senior Note due 2047 (Filed With SEC on November 9, 2017)

Underwriting Agreement, dated as of October 31, 2017, among the Company and Barclays Capital Inc., Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, J.P. Morgan... (Filed With SEC on November 1, 2017)

CelgeneCorporation 2017Stock Incentive Plan (Amendedand Restated as of April 19, 2017) Article 1. PURPOSE (Filed With SEC on June 14, 2017)

SIGNATURE PAGE (Filed With SEC on April 27, 2017)

CELGENE CORPORATION STOCK OPTION AGREEMENT PURSUANT TO THE 2008 STOCK INCENTIVE PLAN (Amended & Restated as of April 15, 2015) (As Further Amended as of June 15, 2016) (Filed With SEC on February 10, 2017)

RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (Amended & Restated as of April 15, 2015) (As Further Amended as of June 15, 2016)... (Filed With SEC on February 10, 2017)

PERFORMANCE STOCK UNIT AGREEMENT PURSUANT TO THE CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (Amended and Restated as of April 15, 2015) (Amended & Restated as of June 15, 2016) (Filed With SEC on February 10, 2017)

AMENDMENT TO THE CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (AMENDED AND RESTATED AS OF APRIL 15, 2015) (Filed With SEC on June 15, 2016)

Fiscal Quarter EndingMaximum RatioSeptember 30, 20155.25:1.00December 31, 2015 to March 31, 20164.95:1.00June 30, 2016 to September 30, 20164.25:1.00December 31, 2016 to March 31,... (Filed With SEC on May 3, 2016)

[Remainder of page intentionally left blank] (Filed With SEC on May 3, 2016)

AMENDMENT NO. 3 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 3, 2016)

AMENDMENT NO. 4 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 3, 2016)

JPMORGAN CHASE BANK, N.A. 383 Madison Avenue New York, NY 10179 (Filed With SEC on October 19, 2015)

CELGENE CORPORATION, as Issuer, and TheBank of New York Mellon Trust Company, N.A., as Trustee INDENTURE Dated as of August 12, 2015 (Filed With SEC on August 12, 2015)

Form of 2.125% Senior Note due 2018 GLOBAL SECURITY (Filed With SEC on August 12, 2015)

Form of 2.875% Senior Note due 2020 GLOBAL SECURITY (Filed With SEC on August 12, 2015)

Form of 3.550% Senior Note due 2022 GLOBAL SECURITY (Filed With SEC on August 12, 2015)

Form of 3.875% Senior Note due 2025 GLOBAL SECURITY (Filed With SEC on August 12, 2015)

Form of 5.000% Senior Note due 2045 GLOBAL SECURITY (Filed With SEC on August 12, 2015)

CELGENE CORPORATION $1,000,000,000 2.125% SENIOR NOTESDUE 2018 $1,500,000,000 2.875% SENIOR NOTESDUE 2020 $1,000,000,000 3.550% SENIOR NOTESDUE 2022 $2,500,000,000 3.875% SENIOR... (Filed With SEC on August 4, 2015)

Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015) Article 1. PURPOSE (Filed With SEC on July 28, 2015)

AGREEMENT AND PLAN OF MERGER by and among CELGENE CORPORATION, STRIX CORPORATION and RECEPTOS, INC. Dated as of July 14, 2015 (Filed With SEC on July 15, 2015)

JPMorganChase Bank, N.A. J.P.Morgan Securities LLC 383 Madison Avenue New York, NY 10179 (Filed With SEC on July 15, 2015)

Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015) Article 1. PURPOSE (Filed With SEC on June 18, 2015)

U.S. $1,750,000,000 SECOND AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 17, 2015 Among CELGENE CORPORATION as Borrower and THE INITIAL LENDERS NAMED HEREIN as Initial... (Filed With SEC on April 20, 2015)

LICENSE AGREEMENT (Filed With SEC on July 29, 2014)

AMENDMENT No. 1 To CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (AMENDED AND RESTATED AS OF APRIL 17, 2013) (Filed With SEC on June 19, 2014)

CELGENECORPORATION, as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of May 15, 2014 (Filed With SEC on May 15, 2014)

Form of 2.250% Senior Note due 2019 GLOBAL SECURITY (Filed With SEC on May 15, 2014)

Form of 3.625% Senior Note due 2024 GLOBAL SECURITY (Filed With SEC on May 15, 2014)

Form of 4.625% Senior Note due 2044 GLOBAL SECURITY (Filed With SEC on May 15, 2014)

CELGENE CORPORATION $500,000,000 2.250% SENIOR NOTES DUE 2019 $1,000,000,000 3.625% SENIOR NOTES DUE 2024 $1,000,000,000 4.625% SENIOR NOTES DUE 2044 UNDERWRITING AGREEMENT May 6,... (Filed With SEC on May 7, 2014)

CELGENE CORPORATION, as Issuer, and THE BANK OFNEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of August 6, 2013 CROSS-REFERENCE TABLE (Filed With SEC on August 6, 2013)

Form of 2.300% Senior Note due 2018 GLOBAL SECURITY (Filed With SEC on August 6, 2013)

Form of 4.000% Senior Note due 2023 GLOBAL SECURITY (Filed With SEC on August 6, 2013)

Form of 5.250% Senior Note due 2043 GLOBAL SECURITY (Filed With SEC on August 6, 2013)

CELGENE CORPORATION $400,000,000 2.300% SENIOR NOTES DUE 2018 $700,000,000 4.000% SENIOR NOTES DUE 2023 $400,000,000 5.250% SENIOR NOTES DUE 2043 UNDERWRITING AGREEMENT August 1,... (Filed With SEC on August 2, 2013)

CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (AMENDED AND RESTATED AS OF APRIL 17, 2013) Article 1. PURPOSE (Filed With SEC on June 13, 2013)

U.S. $1,500,000,000 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 18, 2013 Among CELGENE CORPORATION as Borrower and THE INITIAL LENDERS NAMED HEREIN as Initial Lenders... (Filed With SEC on April 19, 2013)

CELGENE CORPORATION STOCK OPTION AGREEMENT PURSUANT TO THE 2008 STOCK INCENTIVE PLAN (Amended and Restated as of June 17, 2009) (Filed With SEC on February 15, 2013)

RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (Amended & Restated as of June 17, 2009) (for US employees) (Filed With SEC on February 15, 2013)

CELGENE CORPORATION, as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of August 9, 2012 CROSS-REFERENCE TABLE (Filed With SEC on August 9, 2012)

Form of 1.900% Senior Note due 2017 GLOBAL SECURITY (Filed With SEC on August 9, 2012)

Form of 3.250% Senior Note due 2022 GLOBAL SECURITY (Filed With SEC on August 9, 2012)

CELGENE CORPORATION $500,000,000 1.900% SENIOR NOTES DUE 2017 $1,000,000,000 3.250% SENIOR NOTES DUE 2022 UNDERWRITING AGREEMENT August 6, 2012 August 6, 2012 (Filed With SEC on August 7, 2012)

AMENDMENT NO. 2 TO THE CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (AMENDED AND RESTATED AS OF JUNE 17, 2009) (Filed With SEC on June 15, 2012)

U.S. $1,000,000,000 CREDIT AGREEMENT Dated as of September 2, 2011 Among CELGENE CORPORATION as Borrower and THE INITIAL LENDERS NAMED HEREIN as Initial Lenders and CITIBANK, N.A.... (Filed With SEC on September 6, 2011)

AMENDMENT NO. 1 TO THE CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (AMENDED AND RESTATED AS OF JUNE 17, 2009) (Filed With SEC on June 20, 2011)

CELGENE CORPORATION, as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Datedas of October 7, 2010 (Filed With SEC on October 7, 2010)

CELGENE CORPORATION (Filed With SEC on October 7, 2010)

CELGENE CORPORATION (Filed With SEC on October 5, 2010)

AGREEMENT AND PLAN OF MERGER DATED AS OF JUNE 30, 2010 AMONG CELGENE CORPORATION, ARTISTRY ACQUISITION CORP. AND ABRAXIS BIOSCIENCE, INC. (Filed With SEC on July 1, 2010)

FORM OF CONTINGENT VALUE RIGHTS AGREEMENT by and between CELGENE CORPORATION and [TRUSTEE] Dated as of [], 2010 (Filed With SEC on July 1, 2010)

VOTING AGREEMENT (Filed With SEC on July 1, 2010)

NON-COMPETITION, NON-SOLICITATION AND CONFIDENTIALITY AGREEMENT (Filed With SEC on July 1, 2010)

STOCKHOLDERS AGREEMENT (Filed With SEC on July 1, 2010)

AMENDMENT NO. 2 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on June 18, 2010)

SERVICES AGREEMENT (Filed With SEC on June 18, 2010)

AMENDMENT NO. 2 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on June 18, 2010)

Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of June 17, 2009) Article 1. PURPOSE (Filed With SEC on June 18, 2009)

In August 2000, we acquired Signal Pharmaceuticals, Inc., currently Signal Pharmaceuticals, LLC, d/b/a Celgene Research San Diego, a privately held biopharmaceutical company... (Filed With SEC on February 17, 2009)

Three-Month Periods Ended (Filed With SEC on July 31, 2008)

Celgene Corporation 2008 Stock Incentive Plan Article 1. PURPOSE (Filed With SEC on June 24, 2008)

Three-Month Periods Ended (Filed With SEC on May 12, 2008)

AGREEMENT AND PLAN OF MERGER by and among CELGENE CORPORATION, COBALT ACQUISITION LLC and PHARMION CORPORATION November 18, 2007 (Filed With SEC on November 19, 2007)

VOTING AGREEMENT (Filed With SEC on November 19, 2007)

Three-Month Periods Ended (Filed With SEC on November 2, 2007)

Three-Month Periods Ended (Filed With SEC on August 6, 2007)

Three-Month Period Ended (Filed With SEC on May 9, 2007)

Category

Industry

Companies

Contracts

CELGENE CORP Contracts & Agreements